Global Artemisinin Derivatives Market Insights and Forecast to 2031

Report ID: 1230359 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Artemisinin Derivatives Product Introduction
    1.2 Market by Type
        1.2.1 Global Artemisinin Derivatives Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Dihydroartemisinin
        1.2.3 Artemisunate
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Artemisinin Derivatives Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Malaria Treatment
        1.3.3 Scientific Research
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Artemisinin Derivatives Production
    2.1 Global Artemisinin Derivatives Production Capacity (2017-2028)
    2.2 Global Artemisinin Derivatives Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Artemisinin Derivatives Production by Region
        2.3.1 Global Artemisinin Derivatives Historic Production by Region (2017-2022)
        2.3.2 Global Artemisinin Derivatives Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
3 Global Artemisinin Derivatives Sales in Volume & Value Estimates and Forecasts
    3.1 Global Artemisinin Derivatives Sales Estimates and Forecasts 2017-2028
    3.2 Global Artemisinin Derivatives Revenue Estimates and Forecasts 2017-2028
    3.3 Global Artemisinin Derivatives Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Artemisinin Derivatives Sales by Region
        3.4.1 Global Artemisinin Derivatives Sales by Region (2017-2022)
        3.4.2 Global Sales Artemisinin Derivatives by Region (2023-2028)
    3.5 Global Artemisinin Derivatives Revenue by Region
        3.5.1 Global Artemisinin Derivatives Revenue by Region (2017-2022)
        3.5.2 Global Artemisinin Derivatives Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Artemisinin Derivatives Production Capacity by Manufacturers
    4.2 Global Artemisinin Derivatives Sales by Manufacturers
        4.2.1 Global Artemisinin Derivatives Sales by Manufacturers (2017-2022)
        4.2.2 Global Artemisinin Derivatives Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Artemisinin Derivatives in 2021
    4.3 Global Artemisinin Derivatives Revenue by Manufacturers
        4.3.1 Global Artemisinin Derivatives Revenue by Manufacturers (2017-2022)
        4.3.2 Global Artemisinin Derivatives Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Artemisinin Derivatives Revenue in 2021
    4.4 Global Artemisinin Derivatives Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Artemisinin Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Artemisinin Derivatives Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Artemisinin Derivatives Sales by Type
        5.1.1 Global Artemisinin Derivatives Historical Sales by Type (2017-2022)
        5.1.2 Global Artemisinin Derivatives Forecasted Sales by Type (2023-2028)
        5.1.3 Global Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    5.2 Global Artemisinin Derivatives Revenue by Type
        5.2.1 Global Artemisinin Derivatives Historical Revenue by Type (2017-2022)
        5.2.2 Global Artemisinin Derivatives Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    5.3 Global Artemisinin Derivatives Price by Type
        5.3.1 Global Artemisinin Derivatives Price by Type (2017-2022)
        5.3.2 Global Artemisinin Derivatives Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Artemisinin Derivatives Sales by Application
        6.1.1 Global Artemisinin Derivatives Historical Sales by Application (2017-2022)
        6.1.2 Global Artemisinin Derivatives Forecasted Sales by Application (2023-2028)
        6.1.3 Global Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    6.2 Global Artemisinin Derivatives Revenue by Application
        6.2.1 Global Artemisinin Derivatives Historical Revenue by Application (2017-2022)
        6.2.2 Global Artemisinin Derivatives Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    6.3 Global Artemisinin Derivatives Price by Application
        6.3.1 Global Artemisinin Derivatives Price by Application (2017-2022)
        6.3.2 Global Artemisinin Derivatives Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Artemisinin Derivatives Market Size by Type
        7.1.1 North America Artemisinin Derivatives Sales by Type (2017-2028)
        7.1.2 North America Artemisinin Derivatives Revenue by Type (2017-2028)
    7.2 North America Artemisinin Derivatives Market Size by Application
        7.2.1 North America Artemisinin Derivatives Sales by Application (2017-2028)
        7.2.2 North America Artemisinin Derivatives Revenue by Application (2017-2028)
    7.3 North America Artemisinin Derivatives Sales by Country
        7.3.1 North America Artemisinin Derivatives Sales by Country (2017-2028)
        7.3.2 North America Artemisinin Derivatives Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Artemisinin Derivatives Market Size by Type
        8.1.1 Europe Artemisinin Derivatives Sales by Type (2017-2028)
        8.1.2 Europe Artemisinin Derivatives Revenue by Type (2017-2028)
    8.2 Europe Artemisinin Derivatives Market Size by Application
        8.2.1 Europe Artemisinin Derivatives Sales by Application (2017-2028)
        8.2.2 Europe Artemisinin Derivatives Revenue by Application (2017-2028)
    8.3 Europe Artemisinin Derivatives Sales by Country
        8.3.1 Europe Artemisinin Derivatives Sales by Country (2017-2028)
        8.3.2 Europe Artemisinin Derivatives Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Artemisinin Derivatives Market Size by Type
        9.1.1 Asia Pacific Artemisinin Derivatives Sales by Type (2017-2028)
        9.1.2 Asia Pacific Artemisinin Derivatives Revenue by Type (2017-2028)
    9.2 Asia Pacific Artemisinin Derivatives Market Size by Application
        9.2.1 Asia Pacific Artemisinin Derivatives Sales by Application (2017-2028)
        9.2.2 Asia Pacific Artemisinin Derivatives Revenue by Application (2017-2028)
    9.3 Asia Pacific Artemisinin Derivatives Sales by Region
        9.3.1 Asia Pacific Artemisinin Derivatives Sales by Region (2017-2028)
        9.3.2 Asia Pacific Artemisinin Derivatives Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Artemisinin Derivatives Market Size by Type
        10.1.1 Latin America Artemisinin Derivatives Sales by Type (2017-2028)
        10.1.2 Latin America Artemisinin Derivatives Revenue by Type (2017-2028)
    10.2 Latin America Artemisinin Derivatives Market Size by Application
        10.2.1 Latin America Artemisinin Derivatives Sales by Application (2017-2028)
        10.2.2 Latin America Artemisinin Derivatives Revenue by Application (2017-2028)
    10.3 Latin America Artemisinin Derivatives Sales by Country
        10.3.1 Latin America Artemisinin Derivatives Sales by Country (2017-2028)
        10.3.2 Latin America Artemisinin Derivatives Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Artemisinin Derivatives Market Size by Type
        11.1.1 Middle East and Africa Artemisinin Derivatives Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Artemisinin Derivatives Revenue by Type (2017-2028)
    11.2 Middle East and Africa Artemisinin Derivatives Market Size by Application
        11.2.1 Middle East and Africa Artemisinin Derivatives Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Artemisinin Derivatives Revenue by Application (2017-2028)
    11.3 Middle East and Africa Artemisinin Derivatives Sales by Country
        11.3.1 Middle East and Africa Artemisinin Derivatives Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Artemisinin Derivatives Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 U.A.E
12 Corporate Profiles
    12.1 Sanofi
        12.1.1 Sanofi Corporation Information
        12.1.2 Sanofi Overview
        12.1.3 Sanofi Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Sanofi Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Sanofi Recent Developments
    12.2 KPC Pharmaceuticals
        12.2.1 KPC Pharmaceuticals Corporation Information
        12.2.2 KPC Pharmaceuticals Overview
        12.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 KPC Pharmaceuticals Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 KPC Pharmaceuticals Recent Developments
    12.3 Guangxi Xiancaotang Pharmaceutical
        12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
        12.3.2 Guangxi Xiancaotang Pharmaceutical Overview
        12.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
    12.4 Guilin Pharmaceutical
        12.4.1 Guilin Pharmaceutical Corporation Information
        12.4.2 Guilin Pharmaceutical Overview
        12.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Guilin Pharmaceutical Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Guilin Pharmaceutical Recent Developments
    12.5 Kerui Nanhai Pharmaceutical
        12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
        12.5.2 Kerui Nanhai Pharmaceutical Overview
        12.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Kerui Nanhai Pharmaceutical Recent Developments
    12.6 Shanghai Natural Bio-engineering Co
        12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
        12.6.2 Shanghai Natural Bio-engineering Co Overview
        12.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Shanghai Natural Bio-engineering Co Recent Developments
    12.7 Novanat Bioresource
        12.7.1 Novanat Bioresource Corporation Information
        12.7.2 Novanat Bioresource Overview
        12.7.3 Novanat Bioresource Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 Novanat Bioresource Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Novanat Bioresource Recent Developments
    12.8 Botanical Extracts EPZ Ltd
        12.8.1 Botanical Extracts EPZ Ltd Corporation Information
        12.8.2 Botanical Extracts EPZ Ltd Overview
        12.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Botanical Extracts EPZ Ltd Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Artemisinin Derivatives Industry Chain Analysis
    13.2 Artemisinin Derivatives Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Artemisinin Derivatives Production Mode & Process
    13.4 Artemisinin Derivatives Sales and Marketing
        13.4.1 Artemisinin Derivatives Sales Channels
        13.4.2 Artemisinin Derivatives Distributors
    13.5 Artemisinin Derivatives Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Artemisinin Derivatives Industry Trends
    14.2 Artemisinin Derivatives Market Drivers
    14.3 Artemisinin Derivatives Market Challenges
    14.4 Artemisinin Derivatives Market Restraints
15 Key Finding in The Global Artemisinin Derivatives Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Artemisinin Derivatives Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Dihydroartemisinin
    Table 3. Major Manufacturers of Artemisunate
    Table 4. Major Manufacturers of Others
    Table 5. Global Artemisinin Derivatives Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 6. Global Artemisinin Derivatives Production by Region: 2017 VS 2021 VS 2028 (K MT)
    Table 7. Global Artemisinin Derivatives Production by Region (2017-2022) & (K MT)
    Table 8. Global Artemisinin Derivatives Production Market Share by Region (2017-2022)
    Table 9. Global Artemisinin Derivatives Production by Region (2023-2028) & (K MT)
    Table 10. Global Artemisinin Derivatives Production Market Share by Region (2023-2028)
    Table 11. Global Artemisinin Derivatives Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 12. Global Artemisinin Derivatives Sales by Region (2017-2022) & (K MT)
    Table 13. Global Artemisinin Derivatives Sales Market Share by Region (2017-2022)
    Table 14. Global Artemisinin Derivatives Sales by Region (2023-2028) & (K MT)
    Table 15. Global Artemisinin Derivatives Sales Market Share by Region (2023-2028)
    Table 16. Global Artemisinin Derivatives Revenue by Region (2017-2022) & (US$ Million)
    Table 17. Global Artemisinin Derivatives Revenue Market Share by Region (2017-2022)
    Table 18. Global Artemisinin Derivatives Revenue by Region (2023-2028) & (US$ Million)
    Table 19. Global Artemisinin Derivatives Revenue Market Share by Region (2023-2028)
    Table 20. Global Artemisinin Derivatives Production Capacity by Manufacturers (2017-2022) & (K MT)
    Table 21. Global Artemisinin Derivatives Capacity Market Share by Manufacturers (2017-2022)
    Table 22. Global Artemisinin Derivatives Sales by Manufacturers (2017-2022) & (K MT)
    Table 23. Global Artemisinin Derivatives Sales Market Share by Manufacturers (2017-2022)
    Table 24. Global Artemisinin Derivatives Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 25. Global Artemisinin Derivatives Revenue Share by Manufacturers (2017-2022)
    Table 26. Artemisinin Derivatives Price by Manufacturers 2017-2022 (USD/MT)
    Table 27. Global Artemisinin Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 28. Global Artemisinin Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Derivatives as of 2021)
    Table 29. Artemisinin Derivatives Manufacturing Base Distribution and Headquarters
    Table 30. Manufacturers Artemisinin Derivatives Product Offered
    Table 31. Date of Manufacturers Enter into Artemisinin Derivatives Market
    Table 32. Mergers & Acquisitions, Expansion Plans
    Table 33. Global Artemisinin Derivatives Sales by Type (2017-2022) & (K MT)
    Table 34. Global Artemisinin Derivatives Sales by Type (2023-2028) & (K MT)
    Table 35. Global Artemisinin Derivatives Sales Share by Type (2017-2022)
    Table 36. Global Artemisinin Derivatives Sales Share by Type (2023-2028)
    Table 37. Global Artemisinin Derivatives Revenue by Type (2017-2022) & (US$ Million)
    Table 38. Global Artemisinin Derivatives Revenue by Type (2023-2028) & (US$ Million)
    Table 39. Global Artemisinin Derivatives Revenue Share by Type (2017-2022)
    Table 40. Global Artemisinin Derivatives Revenue Share by Type (2023-2028)
    Table 41. Artemisinin Derivatives Price by Type (2017-2022) & (USD/MT)
    Table 42. Global Artemisinin Derivatives Price Forecast by Type (2023-2028) & (USD/MT)
    Table 43. Global Artemisinin Derivatives Sales by Application (2017-2022) & (K MT)
    Table 44. Global Artemisinin Derivatives Sales by Application (2023-2028) & (K MT)
    Table 45. Global Artemisinin Derivatives Sales Share by Application (2017-2022)
    Table 46. Global Artemisinin Derivatives Sales Share by Application (2023-2028)
    Table 47. Global Artemisinin Derivatives Revenue by Application (2017-2022) & (US$ Million)
    Table 48. Global Artemisinin Derivatives Revenue by Application (2023-2028) & (US$ Million)
    Table 49. Global Artemisinin Derivatives Revenue Share by Application (2017-2022)
    Table 50. Global Artemisinin Derivatives Revenue Share by Application (2023-2028)
    Table 51. Artemisinin Derivatives Price by Application (2017-2022) & (USD/MT)
    Table 52. Global Artemisinin Derivatives Price Forecast by Application (2023-2028) & (USD/MT)
    Table 53. North America Artemisinin Derivatives Sales by Type (2017-2022) & (K MT)
    Table 54. North America Artemisinin Derivatives Sales by Type (2023-2028) & (K MT)
    Table 55. North America Artemisinin Derivatives Revenue by Type (2017-2022) & (US$ Million)
    Table 56. North America Artemisinin Derivatives Revenue by Type (2023-2028) & (US$ Million)
    Table 57. North America Artemisinin Derivatives Sales by Application (2017-2022) & (K MT)
    Table 58. North America Artemisinin Derivatives Sales by Application (2023-2028) & (K MT)
    Table 59. North America Artemisinin Derivatives Revenue by Application (2017-2022) & (US$ Million)
    Table 60. North America Artemisinin Derivatives Revenue by Application (2023-2028) & (US$ Million)
    Table 61. North America Artemisinin Derivatives Sales by Country (2017-2022) & (K MT)
    Table 62. North America Artemisinin Derivatives Sales by Country (2023-2028) & (K MT)
    Table 63. North America Artemisinin Derivatives Revenue by Country (2017-2022) & (US$ Million)
    Table 64. North America Artemisinin Derivatives Revenue by Country (2023-2028) & (US$ Million)
    Table 65. Europe Artemisinin Derivatives Sales by Type (2017-2022) & (K MT)
    Table 66. Europe Artemisinin Derivatives Sales by Type (2023-2028) & (K MT)
    Table 67. Europe Artemisinin Derivatives Revenue by Type (2017-2022) & (US$ Million)
    Table 68. Europe Artemisinin Derivatives Revenue by Type (2023-2028) & (US$ Million)
    Table 69. Europe Artemisinin Derivatives Sales by Application (2017-2022) & (K MT)
    Table 70. Europe Artemisinin Derivatives Sales by Application (2023-2028) & (K MT)
    Table 71. Europe Artemisinin Derivatives Revenue by Application (2017-2022) & (US$ Million)
    Table 72. Europe Artemisinin Derivatives Revenue by Application (2023-2028) & (US$ Million)
    Table 73. Europe Artemisinin Derivatives Sales by Country (2017-2022) & (K MT)
    Table 74. Europe Artemisinin Derivatives Sales by Country (2023-2028) & (K MT)
    Table 75. Europe Artemisinin Derivatives Revenue by Country (2017-2022) & (US$ Million)
    Table 76. Europe Artemisinin Derivatives Revenue by Country (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Artemisinin Derivatives Sales by Type (2017-2022) & (K MT)
    Table 78. Asia Pacific Artemisinin Derivatives Sales by Type (2023-2028) & (K MT)
    Table 79. Asia Pacific Artemisinin Derivatives Revenue by Type (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Artemisinin Derivatives Revenue by Type (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Artemisinin Derivatives Sales by Application (2017-2022) & (K MT)
    Table 82. Asia Pacific Artemisinin Derivatives Sales by Application (2023-2028) & (K MT)
    Table 83. Asia Pacific Artemisinin Derivatives Revenue by Application (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Artemisinin Derivatives Revenue by Application (2023-2028) & (US$ Million)
    Table 85. Asia Pacific Artemisinin Derivatives Sales by Region (2017-2022) & (K MT)
    Table 86. Asia Pacific Artemisinin Derivatives Sales by Region (2023-2028) & (K MT)
    Table 87. Asia Pacific Artemisinin Derivatives Revenue by Region (2017-2022) & (US$ Million)
    Table 88. Asia Pacific Artemisinin Derivatives Revenue by Region (2023-2028) & (US$ Million)
    Table 89. Latin America Artemisinin Derivatives Sales by Type (2017-2022) & (K MT)
    Table 90. Latin America Artemisinin Derivatives Sales by Type (2023-2028) & (K MT)
    Table 91. Latin America Artemisinin Derivatives Revenue by Type (2017-2022) & (US$ Million)
    Table 92. Latin America Artemisinin Derivatives Revenue by Type (2023-2028) & (US$ Million)
    Table 93. Latin America Artemisinin Derivatives Sales by Application (2017-2022) & (K MT)
    Table 94. Latin America Artemisinin Derivatives Sales by Application (2023-2028) & (K MT)
    Table 95. Latin America Artemisinin Derivatives Revenue by Application (2017-2022) & (US$ Million)
    Table 96. Latin America Artemisinin Derivatives Revenue by Application (2023-2028) & (US$ Million)
    Table 97. Latin America Artemisinin Derivatives Sales by Country (2017-2022) & (K MT)
    Table 98. Latin America Artemisinin Derivatives Sales by Country (2023-2028) & (K MT)
    Table 99. Latin America Artemisinin Derivatives Revenue by Country (2017-2022) & (US$ Million)
    Table 100. Latin America Artemisinin Derivatives Revenue by Country (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Artemisinin Derivatives Sales by Type (2017-2022) & (K MT)
    Table 102. Middle East and Africa Artemisinin Derivatives Sales by Type (2023-2028) & (K MT)
    Table 103. Middle East and Africa Artemisinin Derivatives Revenue by Type (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Artemisinin Derivatives Revenue by Type (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Artemisinin Derivatives Sales by Application (2017-2022) & (K MT)
    Table 106. Middle East and Africa Artemisinin Derivatives Sales by Application (2023-2028) & (K MT)
    Table 107. Middle East and Africa Artemisinin Derivatives Revenue by Application (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Artemisinin Derivatives Revenue by Application (2023-2028) & (US$ Million)
    Table 109. Middle East and Africa Artemisinin Derivatives Sales by Country (2017-2022) & (K MT)
    Table 110. Middle East and Africa Artemisinin Derivatives Sales by Country (2023-2028) & (K MT)
    Table 111. Middle East and Africa Artemisinin Derivatives Revenue by Country (2017-2022) & (US$ Million)
    Table 112. Middle East and Africa Artemisinin Derivatives Revenue by Country (2023-2028) & (US$ Million)
    Table 113. Sanofi Corporation Information
    Table 114. Sanofi Description and Major Businesses
    Table 115. Sanofi Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 116. Sanofi Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Sanofi Recent Development
    Table 118. KPC Pharmaceuticals Corporation Information
    Table 119. KPC Pharmaceuticals Description and Major Businesses
    Table 120. KPC Pharmaceuticals Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 121. KPC Pharmaceuticals Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. KPC Pharmaceuticals Recent Development
    Table 123. Guangxi Xiancaotang Pharmaceutical Corporation Information
    Table 124. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses
    Table 125. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 126. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Guangxi Xiancaotang Pharmaceutical Recent Development
    Table 128. Guilin Pharmaceutical Corporation Information
    Table 129. Guilin Pharmaceutical Description and Major Businesses
    Table 130. Guilin Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 131. Guilin Pharmaceutical Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Guilin Pharmaceutical Recent Development
    Table 133. Kerui Nanhai Pharmaceutical Corporation Information
    Table 134. Kerui Nanhai Pharmaceutical Description and Major Businesses
    Table 135. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 136. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Kerui Nanhai Pharmaceutical Recent Development
    Table 138. Shanghai Natural Bio-engineering Co Corporation Information
    Table 139. Shanghai Natural Bio-engineering Co Description and Major Businesses
    Table 140. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 141. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Shanghai Natural Bio-engineering Co Recent Development
    Table 143. Novanat Bioresource Corporation Information
    Table 144. Novanat Bioresource Description and Major Businesses
    Table 145. Novanat Bioresource Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 146. Novanat Bioresource Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Novanat Bioresource Recent Development
    Table 148. Botanical Extracts EPZ Ltd Corporation Information
    Table 149. Botanical Extracts EPZ Ltd Description and Major Businesses
    Table 150. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 151. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Botanical Extracts EPZ Ltd Recent Development
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Artemisinin Derivatives Distributors List
    Table 156. Artemisinin Derivatives Customers List
    Table 157. Artemisinin Derivatives Market Trends
    Table 158. Artemisinin Derivatives Market Drivers
    Table 159. Artemisinin Derivatives Market Challenges
    Table 160. Artemisinin Derivatives Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Artemisinin Derivatives Product Picture
    Figure 2. Global Artemisinin Derivatives Market Share by Type in 2021 & 2028
    Figure 3. Dihydroartemisinin Product Picture
    Figure 4. Artemisunate Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Artemisinin Derivatives Market Share by Application in 2021 & 2028
    Figure 7. Malaria Treatment
    Figure 8. Scientific Research
    Figure 9. Others
    Figure 10. Artemisinin Derivatives Report Years Considered
    Figure 11. Global Artemisinin Derivatives Capacity, Production and Utilization (2017-2028) & (K MT)
    Figure 12. Global Artemisinin Derivatives Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Artemisinin Derivatives Production Market Share by Region (2017-2022)
    Figure 14. Global Artemisinin Derivatives Production Market Share by Region (2023-2028)
    Figure 15. Artemisinin Derivatives Production Growth Rate in North America (2017-2028) & (K MT)
    Figure 16. Artemisinin Derivatives Production Growth Rate in Europe (2017-2028) & (K MT)
    Figure 17. Artemisinin Derivatives Production Growth Rate in China (2017-2028) & (K MT)
    Figure 18. Artemisinin Derivatives Production Growth Rate in Japan (2017-2028) & (K MT)
    Figure 19. Global Artemisinin Derivatives Sales 2017-2028 (K MT)
    Figure 20. Global Artemisinin Derivatives Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 21. Global Artemisinin Derivatives Revenue 2017-2028 (US$ Million)
    Figure 22. Global Artemisinin Derivatives Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 23. Global Artemisinin Derivatives Sales Market Share by Region (2017-2022)
    Figure 24. Global Artemisinin Derivatives Sales Market Share by Region (2023-2028)
    Figure 25. North America Artemisinin Derivatives Sales YoY (2017-2028) & (K MT)
    Figure 26. North America Artemisinin Derivatives Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Artemisinin Derivatives Sales YoY (2017-2028) & (K MT)
    Figure 28. Europe Artemisinin Derivatives Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Artemisinin Derivatives Sales YoY (2017-2028) & (K MT)
    Figure 30. Asia-Pacific Artemisinin Derivatives Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Latin America Artemisinin Derivatives Sales YoY (2017-2028) & (K MT)
    Figure 32. Latin America Artemisinin Derivatives Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. Middle East & Africa Artemisinin Derivatives Sales YoY (2017-2028) & (K MT)
    Figure 34. Middle East & Africa Artemisinin Derivatives Revenue YoY (2017-2028) & (US$ Million)
    Figure 35. The Artemisinin Derivatives Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 36. The Top 5 and 10 Largest Manufacturers of Artemisinin Derivatives in the World: Market Share by Artemisinin Derivatives Revenue in 2021
    Figure 37. Artemisinin Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 38. Global Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    Figure 39. Global Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    Figure 40. Global Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    Figure 41. Global Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    Figure 42. North America Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    Figure 43. North America Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    Figure 44. North America Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    Figure 45. North America Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    Figure 46. North America Artemisinin Derivatives Sales Share by Country (2017-2028)
    Figure 47. North America Artemisinin Derivatives Revenue Share by Country (2017-2028)
    Figure 48. U.S. Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 49. Canada Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 50. Europe Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    Figure 51. Europe Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    Figure 52. Europe Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    Figure 53. Europe Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    Figure 54. Europe Artemisinin Derivatives Sales Share by Country (2017-2028)
    Figure 55. Europe Artemisinin Derivatives Revenue Share by Country (2017-2028)
    Figure 56. Germany Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 57. France Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 58. U.K. Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 59. Italy Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 60. Russia Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 61. Asia Pacific Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    Figure 62. Asia Pacific Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    Figure 63. Asia Pacific Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    Figure 64. Asia Pacific Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    Figure 65. Asia Pacific Artemisinin Derivatives Sales Share by Region (2017-2028)
    Figure 66. Asia Pacific Artemisinin Derivatives Revenue Share by Region (2017-2028)
    Figure 67. China Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 68. Japan Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 69. South Korea Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 70. India Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 71. Australia Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 72. Taiwan Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 73. Indonesia Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 74. Thailand Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 75. Malaysia Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 76. Philippines Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 77. Latin America Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    Figure 78. Latin America Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    Figure 79. Latin America Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    Figure 80. Latin America Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    Figure 81. Latin America Artemisinin Derivatives Sales Share by Country (2017-2028)
    Figure 82. Latin America Artemisinin Derivatives Revenue Share by Country (2017-2028)
    Figure 83. Mexico Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 84. Brazil Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 85. Argentina Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 86. Middle East and Africa Artemisinin Derivatives Sales Market Share by Type (2017-2028)
    Figure 87. Middle East and Africa Artemisinin Derivatives Revenue Market Share by Type (2017-2028)
    Figure 88. Middle East and Africa Artemisinin Derivatives Sales Market Share by Application (2017-2028)
    Figure 89. Middle East and Africa Artemisinin Derivatives Revenue Market Share by Application (2017-2028)
    Figure 90. Middle East and Africa Artemisinin Derivatives Sales Share by Country (2017-2028)
    Figure 91. Middle East and Africa Artemisinin Derivatives Revenue Share by Country (2017-2028)
    Figure 92. Turkey Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 93. Saudi Arabia Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 94. U.A.E Artemisinin Derivatives Revenue (2017-2028) & (US$ Million)
    Figure 95. Artemisinin Derivatives Value Chain
    Figure 96. Artemisinin Derivatives Production Process
    Figure 97. Channels of Distribution
    Figure 98. Distributors Profiles
    Figure 99. Bottom-up and Top-down Approaches for This Report
    Figure 100. Data Triangulation
    Figure 101. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Frequently Asked Questions
Artemisinin Derivatives report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Artemisinin Derivatives report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Artemisinin Derivatives report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ionone

Ionone market is segmented by Type and by Application. Players, stakeholders, and other participa ... Read More

Pinocarveol

Pinocarveol market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Myrtenol

Myrtenol market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More

Verbenol

Verbenol market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More